Capgemini Applauded by Frost & Sullivan for Enabling Businesses in the Life Sciences Industry to Transform and Manage Their Processes with Its End-to-end Digital Transformation and Technology Services.

ENPNewswire-January 12, 2022--Capgemini Applauded by Frost & Sullivan for Enabling Businesses in the Life Sciences Industry to Transform and Manage Their Processes with Its End-to-end Digital Transformation and Technology Services

(C)2022 ENPublishing - http://www.enpublishing.co.uk

Release date- 11012022 - Capgemini's solutions help life sciences businesses derive meaningful insights from emerging data, streamline clinical and operational processes, and better manage transformative change.

Capgemini Applauded by Frost & Sullivan for Enabling Businesses in the Life Sciences Industry to Transform and Manage Their Processes with Its End-to-end Digital Transformation and Technology Services

Frost & Sullivan analyzed global digital transformation services in the life sciences industry and, based on its findings, recognizes Capgemini with the 2021 Global Company of the Year Award for digital transformation services within life sciences. Capgemini has transformed how life sciences companies manage change and streamline clinical and operational processes, in addition to obtaining insights from emerging data. The digitized transformation solutions help life sciences companies optimize important processes, such as clinical trials and supply chains, to promote data-driven workflow deployment.

Capgemini's customized data-driven solutions optimize the value chain, helping life sciences businesses scale up from strategy to implementation. The company's end-to-end solutions allow companies in the life sciences industry to reinforce drug discovery, value chain manufacturing capacities, and preclinical and clinical trials. The company's industry-leading intelligent solutions leverage artificial intelligence (AI), data, and intelligent systems to optimize development processes, enhance efficiencies, and quicken the discovery of therapies and drugs for different health conditions. Capgemini's AI Studio for Drug Discovery is highly scalable, flexible, and based on detailed data science and AI innovation partnerships. This solution enhances quality, improves research and development cycle times, and automates sophisticated processes. Intelligent Clinical Trials improve and transform the planning, modeling, and conducting of clinical trials.

According to Frost & Sullivan industry analyst, Unmesh Lal, 'The advanced solution accelerates time-to-market, reduces costs, and improves patient engagement by leveraging AI, analytics, and digital platforms. The...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT